Title: Carla Boccaccio: Innovator in Cancer Treatment
Introduction
Carla Boccaccio is an accomplished inventor based in Torino, Italy. She is currently associated with Metheresis Translational Research S.A. Although she has not yet been granted any patents, her work focuses on innovative approaches to enhance cancer treatment.
Latest Patent Applications
Carla Boccaccio's latest patent application is titled "Met Inhibitors for Enhancing Radiotherapy Efficacy." This application involves a Met inhibitor and/or nucleotide sequence encoding a Met inhibitor for use in the treatment of patients suffering from cancer. The goal is to reduce and/or abrogate patients' resistance to radiotherapy. The Met inhibitor is selected from various options, including an anti-Met monoclonal antibody, a genetically engineered antibody containing the complementarity determining regions (CDRs) of the anti-Met monoclonal antibody, and fragments of these antibodies containing the CDRs, or combinations thereof.
Conclusion
Carla Boccaccio is making significant strides in the field of cancer treatment through her innovative research and patent applications. Her work has the potential to improve the efficacy of radiotherapy for cancer patients.